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This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).SUMMARYConventional generation of stem cells from human blastocysts produces a developmentally advanced, or primed, stage of pluripotency.
In vitro resetting to a more naive phenotype has been reported. However, whether the reset culture conditions of selective kinase inhi-
bition can enable capture of naive epiblast cells directly from the embryo has not been determined. Here, we show that in these specific
conditions individual inner cellmass cells grow into colonies thatmay then be expanded overmultiple passageswhile retaining a diploid
karyotype and naive properties. The cells express hallmark naive pluripotency factors and additionally display features of mitochondrial
respiration, global gene expression, and genome-wide hypomethylation distinct from primed cells. They transition through primed plu-
ripotency into somatic lineage differentiation. Collectively these attributes suggest classification as human naive embryonic stem cells.
Human counterparts of canonicalmouse embryonic stem cells would argue for conservation in the phased progression of pluripotency in
mammals.INTRODUCTION
Human pluripotent stem cells (PSCs), whether derived
from blastocysts or generated by somatic cell reprogram-
ming, differ substantially from canonical mouse embry-
onic stem cells (ESCs) and are considered to represent a
later phase of epiblast development, termed primed plurip-
otency (Hackett and Surani, 2014; Nichols and Smith,
2009; Rossant, 2015). Multiple claims of conversion of
primed human PSCs into a more naive-like phenotype
have been published (reviewed in (Davidson et al.,
2015)). These reports are based on a shift in some attri-
bute(s) in response to exogenous reprogramming factors
and/or altered culture conditions. Evidence has been lack-
ing, however, for a global state that correlates with mouse
ESCs or human naive epiblast (Huang et al., 2014), or for
presence of a functional gene regulatory network to sustain
naive pluripotency (Boroviak et al., 2015; Dunn et al.,
2014; Martello and Smith, 2014).
Two independent studies have described resetting of hu-
man PSCs to resemble mouse ESCs following short-term
expression of KLF2 and NANOG (Takashima et al., 2014;
Theunissen et al., 2014). Reset cells are maintained in me-
dium based on components used for mouse ESCs (Dutta
et al., 2011; Ying et al., 2008) comprising titrated inhibition
of glycogen synthase kinase-3 and blockade of the
mitogen-activated protein kinase (MAPK/Erk) pathway
(t2i) with leukemia inhibitory factor (LIF), plus protein ki-Stemnase C (PKC) inhibition (Takashima et al., 2014). LIF and
t2i have also been used to achieve resetting in combination
with activin plus inhibitors of BRaf, Src family kinases, and
Rho-associated kinase (ROCK) (Theunissen et al., 2014).
Reset pluripotent cells are transcriptionally distinct from
conventional PSCs and more similar to mouse ESCs and
human ICM (Davidson et al., 2015; Huang et al., 2014).
They have increased mitochondrial respiratory activity
and exhibit global DNA hypomethylation (Takashima
et al., 2014), properties consistent with pre-implantation
identity. Perhaps most persuasively, reset cells have ac-
quired expression of, and functional dependency on, tran-
scription factors KLF4 and TFCP2L1 constituting part of
the core gene regulatory network of naive pluripotency in
mouse ESCs (Dunn et al., 2014; Martello et al., 2013;
Niwa et al., 2009; Ye et al., 2013) and are expressed in the
human ICM but negligible in the primed PSC (Takashima
et al., 2014).
In rodents functional equivalence of ESCs with naive
epiblast can be demonstrated by blastocyst colonization
and extensive multilineage contribution to chimeras.
Such an assay is not feasible in human. An alternative indi-
cator of developmental identity is propagation directly
from naive epiblast cells, as for derivation of mouse ESCs
(Boroviak et al., 2014; Brook and Gardner, 1997; Nichols
et al., 2009). In human the standard process for establish-
ing PSC lines from embryos entails explant outgrowth to
form an epithelial structure (Pickering et al., 2003), theCell Reports j Vol. 6 j 437–446 j April 12, 2016 j ª2016 The Authors 437
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Figure 1. Cell Line Derivation from Dissociated Human Inner Cell Mass Cells
(A) Day-6 blastocyst.
(B) Trophoblast lysis.
(C) Discarded trophoblast.
(D) Isolated inner cell mass.
(legend continued on next page)
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Table 1. Derivation of Naive Epiblast Stem Cell Lines
Experiment
Embryos
Surviving
Thaw Blastocystsa
Dissociated
ICMs
Cell
Lines
Cumulative
Passages
1 24 4 1 HNES1 P30
2 9 4 2 HNES2 P22
HNES3 P29
3 20 4 4 HNES4b P21
4 5 2 1 c
Total 58 14 8 4
aEmbryos cavitated by day 6.
bPrimary colonies lost in three cases associated with incubator humidity
failure.
cPrimary colonies emerged but failed to expand after five passages.post-inner cell mass intermediate (PICMI) (O’Leary et al.,
2012). This is thought to simulate development of the
post-implantation embryonic disk (Van der Jeught et al.,
2015), which may explain why derivative cell lines acquire
characteristics of primed pluripotency. Naive pluripotency
factors such as TFCP2L1 are downregulated during PICMI
formation (O’Leary et al., 2012). We elected to test the abil-
ity of culture conditions that sustain human naive PSCs
after resetting in vitro to support de novo derivation from
dissociated human ICMs without PICMI transition.RESULTS
Previous human embryo derivations of PSCs have been
performed in the presence of fibroblast growth factor
(FGF) and/or serum factors, conditions that support devel-
opmental progression. We avoided these and adopted the
culture regime developed for human reset PSCs (Takashima
et al., 2014), comprising serum-free N2B27 medium with
LIF and t2i (inhibitors of GSK3 and MAPK/Erk signaling)
plus the PKC inhibitor Go¨6983. To safeguard viability of
precious embryo cells, we added ascorbic acid and ROCK
inhibitor (Y-27632), constituting t2iLGo¨Y. Cultures were
maintained throughout on fibroblast feeders in 5% O2.(E) Decompacted ICM.
(F) Dissociated ICM.
(G) Primary stem cell clone grown from a single ICM cell.
(H) Colony at passage 8.
(I) qRT-PCR for pluripotency markers in HNES cells, conventional hum
the SD of two independent reactions.
(J) Immunofluorescence of pluripotency markers in HNES1 cells.
(K) Immunofluorescence of KLF17 and NANOG in D6 human ICM cells
Scale bars: 25 mm.
StemICMs were isolated from blastocysts 6 days post-fertiliza-
tion by immunosurgery (Solter and Knowles, 1975).
Following dissociation, single cells or doublets were distrib-
uted on feeders in t2iLGo¨Y. Up to half of the plated ICM
cells formed compact colonies within 4–5 days (Figures
1A–1G), similar to mouse ESC primary colony formation
(Nichols et al., 2009). For each embryo, colonies were
manually picked, dissociated, and pooled. Replated cells
proliferated (Figures 1H and S1A) and from a total of
eight ICMs, four cell lines were established (Table 1) and
provisionally termed human naive embryonic stem
(HNES) cells.
HNES cells were expanded by passaging every 3–4 days,
with ROCK inhibitor and ascorbic acid maintained
throughout. HNES cells can be replated and maintained
without ROCK inhibitor, albeit at lower efficiency, and
propagated without ascorbic acid (Figures S1B–S1D).
They can be cryopreserved and thawed with expected re-
covery efficiency using standard procedures. HNES1 cells
exhibit a consistent 46XY karyotype with no abnormal-
ities detected by G-banding (Figure S1E and Table S1),
while HNES2 comprised both diploid and tetraploid cells
on initial karyotyping but resolved to 46XYafter flow sort-
ing (Figures S1E and S1F). HNES3 is a mix of 46XX and
cells with chr22 trisomy. HNES4 contains two isochromo-
somes of chromosome 12. Array comparative genomic hy-
bridization at 200 kb genome-wide resolution confirmed
lack of chromosomal abnormalities in HNES1. This line
is described below with data from other lines where
specified.
HNES cells expressed mRNAs for naive pluripotency
markers KLF4, TFCP2L1, and DPPA3, along with elevated
NANOG transcripts (Figure 1I) as seen in reset cells gener-
ated from conventional PSCs (Takashima et al., 2014).
Immunostaining confirmed presence of NANOG, KLF4,
TFCP2L1, and OCT4 (Figures 1J and S1G). Expression of
ESRRB andKLF2was low inHNES cells, similar to reset cells.
Both factors are also expressed at low levels in human and
marmoset ICMs, indicating divergence between primates
and rodents (Blakeley et al., 2015; Boroviak et al., 2015).
Another Kruppel-like factor, KLF17, is observed at the tran-
script level in primate ICMs (Blakeley et al., 2015; Boroviak
et al., 2015) and expressed in reset and HNES cellsan PSCs (H9), and in vitro reset PSCs (Reset H9). Error bars indicate
.
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(Figure 1I). We detected KLF17 protein in HNES cells and
human ICMs (Figures 1J and 1K).
Whole-transcriptome profiles were obtained by RNA-seq
from replicate cultures of HNES1, HNES2, and HNES3.
These were compared with reset and conventional human
PSC datasets (Takashima et al., 2014) and to a wider panel
of H1, H7, H9, and H14 data from the public domain.
HNES cells feature a transcriptome distinct from other
PSCs and close to the reset state (Figure 2A). They show
consistent expression of naive pluripotency factors. Con-
ventional PSCs exhibit wider variation in expression pro-
files with sporadic activation of naive factors such as
NANOG, ZFP42 (REX1), and TFCP2L1. HNES cells express
a restricted complement of lineage markers compared
with conventional PSCs. We performed principal compo-
nent analysis (PCA), additionally incorporating published
data (Blakeley et al., 2015; Yan et al., 2013) on human
ICM cells and primary cultures generated by single-cell
RNA-seq (Figure 2B). PC1 primarily discriminates between
cells profiled by single-cell and bulk RNA-seq methods,
suggesting a substantial contribution of global expression
variance by sequencing protocol. Numerous transcripts
present in conventional RNA-seq datasets register zero
read counts in the single-cell libraries, in line with known
detection limitations (Kharchenko et al., 2014). Biological
replicates of the three HNES cells cluster together and adja-
cent to reset H9 cells. PC2 places HNES cells in relative
proximity to the ICM cells and well separated from other
PSCs. The degree of correspondence between HNES and
embryo cells appears reasonable, considering the wider
variation between samples profiled in the embryo studies,
and that early ICM cells analyzed precede naive epiblast.
Markers of naive pluripotency and lineage specification
diverge between HNES and reset cells versus conventional
PSC (Figure 2C).
Primed PSCs rely on anaerobic glycolysis with low mito-
chondrial respiration capacity (Zhou et al., 2012), whereas
reset PSCs have active mitochondria and reduced glucoseFigure 2. Transcriptome and Methylome Analyses
(A) Clustered expression data from HNES cells, and reset and conven
selected by the International Stem Cell Initiative (Adewumi et al., 200
per million reads mapped) scaled by the mean expression of each gen
codes.
(B) PCA of HNES cells, and reset and conventional PSCs with single-c
et al., 2013) and PSC explants. Embryo single-cell samples are those
(C) Pluripotency and lineage marker expression in human ICM, HNES
(D) Proportion of whole-genome CpG methylation measured by bisul
Error bars indicate the SD of three biological replicates.
(E) Comparison of global methylation in HNES1 (male) and HNES3 (fem
(F) Comparisons of CpG methylation in HNES1 cells and primed deriva
(G) PCA of mean CpG island methylation.
(H) CGI methylation in HNES1 and conventional PSCs.
Stemdependence (Takashima et al., 2014). We evaluated the
capacity of HNES cells to form colonies in the presence of
the competitive inhibitor of glycolysis, 2-deoxyglucose.
Undifferentiated HNES cells readily formed colonies while
primed HNES cells generated by passaging in FGF/KSR did
not survive (Figure S2A). HNES cells also stained intensely
with MitoProbe DiIC1, reflecting mitochondrial mem-
brane potential (Figures S2B and S2C). Extracellular flux
analysis indicated that HNES cells exhibit at least 2-fold
higher respiratory capacity than primed cells (Figure S2D).
Global DNA hypomethylation is a distinguishing feature
of mouse and human ICM cells (Guo et al., 2014; Smith
et al., 2012), a property shared with naive ESCs (Ficz
et al., 2013; Habibi et al., 2013; Leitch et al., 2013) and reset
human PSCs (Takashima et al., 2014). Immunostaining for
5-methylcytosine (5mC) is fainter in HNES cell nuclei
compared with primed HNES cells (Figure S3A). Like
reset PSCs, HNES cells show appreciable expression of
TET1 and downregulation of de novo methyltransferase
DNMT3B (Figures S3B and S3C). We performed whole-
genome bisulfite sequencing on two HNES lines and their
primed derivatives. Analysis confirmed genome-wide hy-
pomethylation in male and female HNES cells, similar to
levels of 25%–40%observed in human ICMand in contrast
to >70% CpG methylation in conventional PSCs and
primed HNES cells (Figure 2D). Both HNES lines showed
extensive overlap in the distribution of CpG methylation
sites (Figure 2E), with substantial hypomethylation com-
pared with primed HNES cells (Figure 2F). Themethylomes
of HNES and reset H9 cells are very similar, suggesting that
the epigenetic state of conventional human PSCs can be
accurately and consistently reprogrammed. We analyzed
methylation levels of CpG islands (CGIs) and performed
PCA, revealing clustering of HNES with reset H9 cells and
conventional human PSCs (H9) with primed HNES cells
(Figure 2G). PC1 captured most of the variation (42%),
indicating high resemblance between HNES cells and
human ICMs (Guo et al., 2014). Comparisons of CGItional human PSCs for a panel of pluripotency and lineage markers
7). Displayed are log2 FPKM values (fragments per kilobase of exon
e across samples. Published data are labeled with sample accession
ell RNA-seq data from early human ICMs (Blakeley et al., 2015; Yan
assigned an epiblast identity in the respective studies.
cells, and reset and conventional PSC lines.
fite sequencing (BS-seq) analysis from three biological replicates.
ale) cells by averaging CpGmethylation levels over 500-kb windows.
tives, and reset H9 and ICM cells.
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methylation in HNES and H9 cells (Figure 2H) showed that
the majority of CGIs are hypomethylated in both HNES
cells and conventional PSCs, while many CGIs gain
methylation in primed cells. Only a subset of CGIs is meth-
ylated in both conditions. These data highlight similarity
between HNES and human ICM methylomes and show
that conventional human PSCs have gained methylation
at a number of CGIs when compared with HNES cells.
We transferred HNES cells to conventional PSC culture
medium containing FGF/KSR and lacking inhibitors. After
one passage the domed colonies of HNES cells assumed
flattened epithelial morphology, and after two passages
resembled conventional PSC (Figure 3A). During this
transition OCT4 and NANOG were reduced, and naive
markers, including KLF17, were extinguished (Figures 3B,
S4A, and S4B).
We assessed whether HNES cells can undergo multiline-
age differentiation by generating embryoid bodies directly
from naive and primed HNES cells. In both cases early line-
age markers PAX6, MIXL1, and SOX17 were upregulated
(Figure 3C). Outgrowths from plated embryoid bodies dis-
played TuJ1-positive neuronal, FOXA2/AFP double-posi-
tive endoderm, and smooth muscle actin-positive cells
(Figure 3D). We also applied a protocol for cardiomyocyte
differentiation (van den Berg et al., 2016) to primed
HNES cells and observed multiple regions of spontaneous
contraction after 12 days (Movie S1). Cardiomyocyte
identity was confirmed by expression of surface markers
VCAM-1 and CD172a (SIRPa) (Figure S4C).DISCUSSION
Hitherto, stem cell derivations from human embryos have
yielded cells with features distinct from rodent ESCs and
more similar to mouse post-implantation epiblast-derived
stem cells (Brons et al., 2007; Tesar et al., 2007). This may
be because the culture conditions used were inadequate
to sustain naive pluripotency in the face of stimuli for
developmental progression emanating from extraembry-
onic endoderm (Brook andGardner, 1997) in ICM explants
and/or provided by FGF and serum factors. Even for deriva-
tions commencing from single blastomeres, a blastocyst-
like structure develops, followed by ICM outgrowth prior
to cell line derivation (Taei et al., 2013). We show that afterFigure 3. Differentiation
(A) Colonies of naive HNES1 cells in t2iLGo¨Y and primed HNES1 cells
(B) qRT-PCR analysis of naive marker expression in naive HNES1 cells
the SD of two independent reactions.
(C) qRT-PCR analysis of embryoid bodies formed from HNES1 and prime
(D) Immunofluorescence of embryoid body outgrowths: TuJ1, b-III
FOXA2 (red). Nuclei (DAPI; blue). Scale bars, 100 mm.
Stemdissociation of the ICM to separate epiblast and primitive
endoderm, stem cell colonies emerge directly in the pres-
ence of inhibitors of MAPK/Erk, GSK3, and PKC. Resulting
HNES cell lines can be propagated by enzymatic dissocia-
tion to single cells, retain chromosomal integrity over
many passages, exhibit features diagnostic of naive plurip-
otency, and are capable of multilineage differentiation.
Conventional human PSC cultures are heterogeneous,
potentially comprising complex hierarchies (Davidson
et al., 2015; Enver et al., 2009; Hough et al., 2014). Further-
more, pluripotency is an inherently plastic stage of devel-
opment. It is unsurprising, therefore, that PSCs can adjust
to alternative culture conditions with shifts inmorphology
and gene expression. Without objective criteria, these may
be misinterpreted as a change in developmental status
rather than accommodation to culture. In contrast, global
transcriptome, metabolic properties, and DNA hypome-
thylation features align HNES cells with reset PSCs and
distinguish them from conventional human PSCs. Of
particular significance, HNES cells and reset PSCs express
the naive pluripotency factors KLF4, TFCP2L1, TBX3, and
NANOG found in the primate ICMs and functional in
mouse ESC self-renewal. Additionally they express KLF17,
which might compensate for lower expression of KLF2.
Apart from NANOG, these factors are expressed at low
levels or not at all in conventional human PSCs, including
those variants purported to be naive by other criteria. We
have shown that the reset PSC state is dependent on both
KLF4 and TFCP2L1 (Takashima et al., 2014).
The naive gene regulatory network is not fully conserved
between mouse and human. Absence of ESRRB marks a
substantial distinction. Mouse ESCs can be maintained af-
ter deletion of Esrrb but are less stable (Martello et al., 2012).
Lack of ESRRB may therefore render human naive PSC
propagation inherently more demanding. Nonetheless,
culture refinements and replacement of feeders with a
defined substrate may be anticipated to facilitate their
handling and possibly attainment of a ground state.
In summary, these findings suggest that it is possible to
suspend human developmental progression at the pre-im-
plantation epiblast phase and propagate a self-renewing
pluripotent state analogous to mouse ESCs (Boroviak
et al., 2014; Brook and Gardner, 1997). Derivation of
equivalent cell lines from non-human primates and forma-
tion of high-contribution chimeras would provide furtherafter 12 passages in FGF/KSR.
and derivatives after three passages in FGF/KSR. Error bars indicate
d HNES1 cells. Error bars indicate the SD two independent reactions.
tubulin; AFP, a-fetoprotein; SMA, a-smooth muscle actin (green);
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validation. However, our results support the case for naive
pluripotency in human development and may reconcile
the long-running debate about the difference between
PSCs from mice and men.EXPERIMENTAL PROCEDURES
Embryo Manipulation
Supernumerary frozen human embryos were donated with
informed consent under license from the UK HFEA. Embryos
were thawed using EmbryoThaw medium (FertiPro) and cultured
in drops of pre-equilibrated medium (Origio): EmbryoAssist for
1–8 cell stage (days 0–2), and BlastAssist for 8 cell stage to blastocyst
(days 3–6) under embryo-tested mineral oil (Sigma). Expanded
blastocysts (day 6) were subjected to immunosurgery (Pickering
et al., 2005) to isolate ICMs using anti-human serum (Sigma).
ICMs were treated with Accutase (Sigma or Gibco) for 5–10 min,
and placed in a drop of medium for mechanical separation using
a finely drawn Pasteur pipette. ICM cells were scattered onto
mitotically inactivated (irradiated) murine embryonic fibroblasts
(MEFs). Immunostaining was performed as described by Taka-
shima et al. (2014).
Naive Stem Cell Culture
Cells were propagated in modified N2B27 medium supplemented
with PD0325901 (1 mM, prepared in-house), CHIR99021 (1 mM,
prepared in-house), Go¨6983 (2.5 mM, Sigma-Aldrich), rho-associ-
ated kinase inhibitor (Y-27632) (10 mM, Calbiochem), human LIF
(10 ng/ml, prepared in-house), and ascorbic acid (250 mM, Sigma).
N2B27 medium (1 l) comprised 490 ml of DMEM/F12 (Life Tech-
nologies), 490 ml of Neurobasal (Life Technologies), 10 ml of B27
(Life Technologies), 5 ml of N2 (prepared in-house), 10 mg/ml insu-
lin (Sigma), 2 mM L-glutamine (Life Technologies), and 0.1 mM
2-mercaptoethanol (Sigma). N2 contains 100 mg/ml apo-trans-
ferrin (eBioscience, ABC2553), 3 mM sodium selenite (Sigma),
1.6 mg/ml putrescine (Sigma), and 2 mg/ml progesterone (Sigma)
in DMEM/F12 (Life Technologies). Primary colonies and nascent
cell lines were passaged manually as described above for ICMs.
Established cells were passaged either manually with Accutase
(Life Technologies) dissociation reagent or as a pool using TrypLE
Express (Life Technologies). Cells were cultured in 5% O2 and 7%
CO2 in a humidified incubator at 37
C. Cells were frozen in 50%
t2iLGo¨Y medium with 40% serum and 10% DMSO.
Conversion to Primed Pluripotency
HNES cells were seeded on MEFs in t2iLGo¨Y for 24 hr, then trans-
ferred into FGF/KSR medium for 7–10 days before passaging with
TrypLE Express. Y-27632 was added for the first passage. Thereafter
cells were passaged as clusters using collagenase/dispase (Roche).
FGF/KSR medium comprised 20% KnockOut Serum Replacement
(Invitrogen), 13 non-essential amino acids (Invitrogen), 2 mM
L-glutamine (Invitrogen), 100 mM 2-mercaptoethanol (Sigma),
10 ng/ml FGF2 (prepared in-house), and DMEM/F-12 basal me-
dium (Sigma-Aldrich). Established primed HNES cultures can also
be maintained in mTeSR1 or E8 media (StemCell Technologies)
on Matrigel.444 Stem Cell Reports j Vol. 6 j 437–446 j April 12, 2016 j ª2016 The AuthoIn Vitro Differentiation
HNES cells or primed derivatives were dissociated with TrypLE Ex-
press and placed in PrimeSurface 96V cell plates (Sumitomo Bake-
liteMS-9096V) at a density of 4,000–5,000 cells per well inmedium
containing 20% KSR. Y-27632 was added during the first 24 hr of
aggregation. At day 7 aggregates were plated on gelatin in 20% FBS.
Cardiomyocyte differentiation was performed as described by
van den Berg et al. (2016).
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